HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Lauder Distribution Diversification Calls For “Meaningful Investment” In ’O4

This article was originally published in The Rose Sheet

Executive Summary

Estee Lauder has set aside funds in its fiscal 2004 plan to make a "meaningful investment" in a new distribution diversification initiative, President and CEO Fred Langhammer stated in a fourth quarter and year-end sales and earnings release Aug. 14

You may also be interested in...



Lauder Banks On Kohl’s Beauty In Distribution Expansion Move

Estee Lauder is launching an initiative to develop multiple beauty brands for distribution exclusively in Kohl's as part of an alliance with the retailer announced Oct. 28

Lauder Banks On Kohl’s Beauty In Distribution Expansion Move

Estee Lauder is launching an initiative to develop multiple beauty brands for distribution exclusively in Kohl's as part of an alliance with the retailer announced Oct. 28

Darphin Revamped Nuances D’Aromes Line Offers New Colors, SPF Protection

Darphin will promote the relaunch of its Nuances D'Aromes cosmetics collection with an extensive sampling effort and co-op ads breaking in retailers' fall catalogs, U.S. President Jean-Marc Benet said

Latest News
See All
UsernamePublicRestriction

Register

RS011446

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel